Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus
Conditions: Diabetes Mellitus; Tuberculosis Interventions: Drug: Isoniazid and Rifapentine (INH-RPT); Drug: Placebo Sponsors: Dr. Nyanda Elias Ntinginya; Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands; Otago University, New Zealand; Makerere University; St George's, University of London, United Kingdom; Kilimanjaro Christian Medical University College (KCMUCo), Tanzania; Uganda Martyrs Hospital Lubaga, Uganda; King's College London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Endocrinology | Netherlands Health | New Zealand Health | Research | Tanzania Health | Tuberculosis | Uganda Health